All abstracts
Home
Scientific Programme
Industry Sessions
Live Sessions
Abstracts
E-posters
Sponsors and Exhibitors
All
Posters
Topics
Presentation Type
Loading
Clear all filters
EPP083
Comparison of Aerobic Fitness in Patients with Schizophrenia and Healthy Adults
EPP084
Anandamide in First-Episode Psychosis: Associations with Symptoms and Inflammation
EPP085
Patient perspectives on 3-monthly paliperidone long-acting injections (PP3M): real-world questionnaire data from South London community mental health teams
EPP086
The effectiveness of non-pharmacological treatments for auditory verbal hallucinations in schizophrenia spectrum disorders: a systematic review and meta-analysis
EPP087
Precision medicine in schizophrenia: stratifying patients by inflammatory, metabolic, and gut-brain biomarker profiles using latent profile analysis
EPP088
Switching from Amisulpride to Cariprazine: Real-world outcomes in patients with predominant negative symptoms
EPP090
An open-label trial to compare exposures of subcutaneous long-acting injectable use olanzapine (TV-44749) versus oral olanzapine in adults with schizophrenia (ORBIT)
EPP091
A study of cognition and functional outcome in patients acutely admitted to hospital with schizophrenia, mania or depression
EPP092
OGTT-Defined Insulin Resistance in Adults With Schizophrenia and Schizoaffective Disorder: Comparing Clozapine versus other Antipsychotics
EPP093
Do hospitalisation rates increase following discharge from an Early Intervention for Psychosis service? A naturalistic cohort study.
EPP094
Chlorpromazine-induced lupus anticoagulant unveiled by transient ischemic attack: a case report with 3-year follow-up
EPP095
The effect of prebiotics on the gut microbiota in patients treated with atypical antipsychotics: a pilot study
EPP096
Clozapine-resistant patients: new treatment lines in schizophrenia
EPP097
Theory of Mind Variability in Schizophrenia: A Neurodevelopmental Perspective through Neurological Soft Signs and Premorbid Adjustment
EPP098
Behavioural and Genetic Predictors of Positive Symptoms in Psychotic Disorders
EPP099
NEUROLOGICAL SOFT SIGNS AND SOCIAL COGNITION IN PATIENTS WITH SCHIZOPHRENIA: THE MISSING LINK
EPP100
Childhood trauma subtypes and specific symptom expression in first-episode psychosis
EPP101
Evaluation of Death Anxiety in Patients with Schizophrenia
EPP102
Long-acting injectable antipsychotics and long-term functionality in schizophrenia
EPP103
Collaboration and co-design between research experts and experts with lived experience in the TRUSTING project for AI-based relapse risk assessment for individuals with psychosis
1864
abstracts
1
...
3
4
5
6
...
94